Almost half of healthcare consumers ready to embrace medical AI

Some 46% of Americans are open to the idea of their physicians using AI to help make diagnoses, according to the latest survey of healthcare consumers annually commissioned by the insurance giant UnitedHealthcare.

The reasons most commonly cited by these early embracers are the technology’s potential to boost diagnostic accuracy (46%), cut the risk of human error (31%) and inform speedy treatment decisions (15%).

Meanwhile, participants who said they weren’t interested in medical AI––28% of respondents––based their nonacceptance on a preference for the expertise of a trained professional (47%) and a lack of trust in the technology (24%).    

The survey was conducted by phone in August. Researchers spoke with a random sample of 1,008 adults who answered via cellphone or landline.

Other noteworthy findings from the same survey: Thirty-seven percent of patients have used the internet or mobile apps over the past year to compare the quality and cost of medical services. That’s a big jump from the 14% who said they’d done so in 2012.

“Technology continues to reshape nearly every aspect of life, including how people research and access healthcare,” Rebecca Madsen, chief consumer officer of UnitedHealthcare, comments in a news item posted by the company.

She says the survey results also highlight the need for new investments in tech-based resources “to help enhance the care experience and provide more effective, evidence-based clinical interventions.”

Click here to read the item and here for the complete survey results.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.